In another stock I own they have been applying for lots and lots of patents. Apparently the company can provide guidance to the ASX if it is price sensitive but the ASX gets the final say.
rough quote from other stock - the ASX doesnt understand the biotech space and doesnt really comprehend the significance of building strong IP protection or the value it can provide later down the track
Ann: US Patent Issued - BARD1 Patent Family Lung Cancer Diagnosis, page-5
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
-0.010(1.75%) |
Mkt cap ! $59.09M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 57.0¢ | 54.0¢ | $96.73K | 176.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12 | 55.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.0¢ | 7999 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |